After-hours movers: WW jumps on Sequence deal, Nutanix falls following results

This post was originally published on this site

WW International, Inc. (NASDAQ:WW) 10% HIGHER; entered into a definitive agreement to acquire Weekend Health, Inc., d/b/a Sequence, a subscription telehealth platform offering access to healthcare providers specializing in chronic weight management. Sequence seamlessly integrates the patient and clinician experience for ongoing, clinical care and medication management while providing high-touch support in navigating the insurance approval process.

Nutanix (NASDAQ:NTNX) 4% LOWER; reported Q2 preliminary revenue $486.5 million versus the consensus estimate of $464.97M. Nutanix sees Q3 2023 revenue of $430-440M, versus the consensus of $425.38M. Nutanix sees FY2023 revenue of $1.8-1.81 billion, versus the consensus of $1.78B.

DXC Technology Co (NYSE:DXC3% LOWER; terminate takeover discussions with financial sponsor due to challenges in raising the necessary capital,

Trip.com Group Ltd ADR (NASDAQ:TCOM) 2% HIGHER; reported Q4 EPS of RMB 0.76 (RMB 1 = $0.14), RMB 1.01 better than the analyst estimate of (RMB 0.25). Revenue for the quarter came in at RMB 5B versus the consensus estimate of RMB 4.85B.

Guidewire Software (NYSE:GWRE) 2% HIGHER; reported Q2 EPS of ($0.21), $0.19 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $232.6M versus the consensus estimate of $223.22M. Guidewire Software sees Q3 2023 revenue of $211-216M, versus the consensus of $213.7M. Guidewire Software sees FY2023 revenue of $894-904M, versus the consensus of $890.66M.

Rivian Automotive Inc (NASDAQ:RIVN1% LOWER; announced its intention to offer, subject to market and other conditions, $1,300,000,000 aggregate principal amount of green convertible senior notes due 2029